Stock PBM PSYENCE BIOMEDICAL LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Psyence Biomedical Ltd.

Equities

PBM

CA74449F1009

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
 03:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
0.3558 USD -3.26% Intraday chart for Psyence Biomedical Ltd. -40.50% -96.15%
18/03 Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin CI
12/03 Psyence Biomedical Ltd. Receives Human Research Ethics Committee Approval to Initiate Phase IIb Study CI

Business Summary

Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The Company has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.

Members of the board

Members of the board TitleAgeSince

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,535,000 0 0 23.59 %
Stock B 1 13,390,659 4,700,730 ( 35.10 %) 0

Shareholders

NameEquities%Valuation
PSYENCE GROUP INC.
37.34 %
5,000,000 37.34 % 4 M $
Newcourt SPAC Sponsor LLC
17.85 %
2,389,929 17.85 % 2 M $
Tabula Rasa Ltd.
9.708 %
1,300,000 9.708 % 975 000 $
Harraden Circle Investments LLC
9.708 %
1,300,000 9.708 % 975 000 $
Cantor Fitzgerald & Co.
6.015 %
805,500 6.015 % 604 125 $
AdvisorShares Investments LLC
2.026 %
271,336 2.026 % 203 502 $
Cowen & Co. LLC
1.160 %
155,287 1.160 % 116 465 $
Two Sigma Securities LLC
0.4165 %
55,776 0.4165 % 41 832 $
Virtu Financial LLC
0.1973 %
26,419 0.1973 % 19 814 $
HRT Financial LLC
0.0942 %
12,611 0.0942 % 9 458 $
NameEquities%Valuation
EHP Funds, Inc.
-
1,232,748 - 36 982 $
Polar Asset Management Partners, Inc.
-
733,000 - 21 990 $
EdgeHill Partners
-
691,188 - 20 736 $
MMCAP International Inc. SPC
-
600,000 - 18 000 $
Calamos Advisors LLC
-
500,000 - 15 000 $
Periscope Capital, Inc.
-
300,000 - 9 000 $
Saba Capital Management LP
-
297,847 - 8 935 $
Aristeia Capital LLC
-
272,857 - 8 186 $
Context Capital Management LLC
-
234,200 - 7 026 $
LMR Partners LLP
-
200,000 - 6 000 $

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
PSYENCE BIOMEDICAL LTD. Stock Psyence Biomedical Ltd.
-96.15% 47.64L
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 81TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 64TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+9.05% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 25TCr
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 22TCr
NOVARTIS AG Stock Novartis AG
+12.47% 22TCr
AMGEN INC. Stock Amgen Inc.
+8.91% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PBM Stock
  4. Company Psyence Biomedical Ltd.